MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

Search

BeOne Medicines Ltd ADR

Closed

SectorHealthcare

344.24 3.2

Overview

Share price change

24h

Current

Min

344.24

Max

354.44

Key metrics

By Trading Economics

Income

93M

94M

Sales

198M

1.3B

Profit margin

7.171

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+7.08% upside

Dividends

By Dow Jones

Next Earnings

10 lis 2025

Market Stats

By TradingEconomics

Market Cap

22B

Previous open

341.04

Previous close

344.24

News Sentiment

By Acuity

50%

50%

149 / 371 Ranking in Healthcare

BeOne Medicines Ltd ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 maj 2025, 02:16 UTC

Major Market Movers

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

29 sty 2025, 15:59 UTC

Major Market Movers

ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene

27 lis 2024, 15:22 UTC

Major Market Movers

BeiGene Shares Up on EU Approval for Gastric, Esophageal Cancer Treatment

21 lis 2024, 14:45 UTC

Major Market Movers

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

22 paź 2024, 18:39 UTC

Major Market Movers

Indaptus Therapeutics Shares Rise After Pact to Develop Cancer Treatment

6 sie 2025, 10:01 UTC

Earnings

BeOne Medicines Narrows FY25 View To Rev $5.0B-$5.3B >ONC

6 sie 2025, 10:01 UTC

Earnings

BeOne Medicines 2Q Rev $1.3B >ONC

6 sie 2025, 10:01 UTC

Earnings

BeOne Medicines 2Q Adj EPS $2.25 >ONC

6 sie 2025, 10:00 UTC

Earnings

BeOne Medicines 2Q EPS 84c >ONC

9 lip 2025, 09:17 UTC

Hot Stocks

Stocks to Watch Wednesday: Freeport-McMoRan, Glencore, Novo Nordisk -- WSJ

7 maj 2025, 10:07 UTC

Earnings

BeiGene Maintains 2025 Expense Guidance of $4.1B to $4.4B >ONC

7 maj 2025, 10:06 UTC

Earnings

BeiGene Backs 2025 Rev $4.9B-$5.3B >ONC

7 maj 2025, 10:05 UTC

Earnings

BeiGene 1Q Net $1.27M >ONC

7 maj 2025, 10:04 UTC

Earnings

BeiGene Says to Rename Company to BeOne Medicines >ONC

7 maj 2025, 10:02 UTC

Earnings

BeiGene 1Q EPS $0.00 >ONC

7 maj 2025, 10:02 UTC

Earnings

BeiGene 1Q Rev Increased 49% >ONC

7 maj 2025, 10:00 UTC

Earnings

BeiGene 1Q Rev $1.12B >ONC

27 lut 2025, 11:07 UTC

Earnings

BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC

27 lut 2025, 11:06 UTC

Earnings

BeiGene 4Q Global BRUKINSA Rev of $828M >ONC

27 lut 2025, 11:06 UTC

Earnings

BeiGene 4Q Loss/Shr 11c >ONC

27 lut 2025, 11:06 UTC

Earnings

BeiGene 4Q Rev $1.13B >ONC

12 lis 2024, 11:01 UTC

Earnings

BeiGene 3Q Loss/Shr 9c >BGNE

12 lis 2024, 11:01 UTC

Earnings

BeiGene 3Q Rev $1B >BGNE

Peer Comparison

Price change

BeOne Medicines Ltd ADR Forecast

Price Target

By TipRanks

7.08% upside

12 Months Forecast

Average 358.88 USD  7.08%

High 399 USD

Low 322 USD

Based on 13 Wall Street analysts offering 12 month price targets forBeOne Medicines Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

12

Buy

1

Hold

0

Sell

Sentiment

By Acuity

149 / 371 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Operating profit

$

About BeOne Medicines Ltd ADR

BeiGene Ltd
help-icon Live chat